Humana Inc. $HUM Stake Decreased by Manning & Napier Advisors LLC

Manning & Napier Advisors LLC cut its holdings in shares of Humana Inc. (NYSE:HUM) by 52.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,293 shares of the insurance provider’s stock after selling 5,888 shares during the period. Manning & Napier Advisors LLC’s holdings in Humana were worth $1,377,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Blue Trust Inc. boosted its position in Humana by 3.6% during the 2nd quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock worth $334,000 after acquiring an additional 48 shares during the period. Private Wealth Management Group LLC raised its stake in shares of Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 48 shares in the last quarter. Ossiam raised its stake in shares of Humana by 1.6% during the second quarter. Ossiam now owns 4,375 shares of the insurance provider’s stock valued at $1,070,000 after purchasing an additional 71 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its position in Humana by 15.9% in the 3rd quarter. MassMutual Private Wealth & Trust FSB now owns 518 shares of the insurance provider’s stock valued at $135,000 after buying an additional 71 shares in the last quarter. Finally, Signaturefd LLC increased its stake in Humana by 4.7% during the 3rd quarter. Signaturefd LLC now owns 1,626 shares of the insurance provider’s stock valued at $423,000 after buying an additional 73 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Robert W. Baird reduced their price target on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research note on Thursday, December 11th. Guggenheim reissued a “buy” rating on shares of Humana in a report on Friday, October 3rd. Evercore ISI began coverage on Humana in a research note on Monday, September 22nd. They set an “in-line” rating and a $295.00 price target for the company. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Finally, Wolfe Research cut their price objective on Humana from $313.00 to $300.00 and set an “outperform” rating for the company in a report on Thursday, November 20th. Eight analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus target price of $292.05.

Humana Price Performance

NYSE HUM opened at $274.17 on Thursday. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The business’s fifty day moving average is $254.24 and its two-hundred day moving average is $263.20. The stock has a market capitalization of $32.98 billion, a P/E ratio of 25.70, a P/E/G ratio of 2.26 and a beta of 0.45. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The business had revenue of $32.65 billion for the quarter, compared to analysts’ expectations of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.The company’s quarterly revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the firm posted $4.16 EPS. On average, research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. Humana’s dividend payout ratio (DPR) is currently 33.18%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.